BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1652975)

  • 1. The c-fgr proto-oncogene: expression in Epstein-Barr-virus-infected B lymphocytes and in cells of the myelomonocytic and granulocytic lineages.
    Patel M; Faulkner L; Katz DR; Brickell PM
    Pathobiology; 1991; 59(4):289-92. PubMed ID: 1652975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proto-oncogene c-fgr is expressed in normal mantle zone B lymphocytes and is developmentally regulated during myelomonocytic differentiation in vivo.
    Link DC; Zutter M
    Blood; 1995 Jan; 85(2):472-9. PubMed ID: 7812001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel c-fgr exon utilized in Epstein-Barr virus-infected B lymphocytes but not in normal monocytes.
    Gutkind JS; Link DC; Katamine S; Lacal P; Miki T; Ley TJ; Robbins KC
    Mol Cell Biol; 1991 Mar; 11(3):1500-7. PubMed ID: 1847500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of c-fgr proto-oncogene expression in Epstein-Barr virus infected B-cell lines.
    Patel M; Leevers SJ; Brickell PM
    Int J Cancer; 1990 Feb; 45(2):342-6. PubMed ID: 2154410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early activation of the proto-oncogene c-fgr during Epstein-Barr virus immortalization.
    Okano M; Davis JR; Brichacek B; Yasuda N; Purtilo DT
    Cancer Lett; 1992 May; 64(1):11-5. PubMed ID: 1317747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
    Knutson JC
    J Virol; 1990 Jun; 64(6):2530-6. PubMed ID: 2159528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the fgr protooncogene product as a function of myelomonocytic cell maturation.
    Notario V; Gutkind JS; Imaizumi M; Katamine S; Robbins KC
    J Cell Biol; 1989 Dec; 109(6 Pt 1):3129-36. PubMed ID: 2687293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. fgr proto-oncogene is expressed during terminal granulocytic differentiation of human promyelocytic HL60 cells.
    Miyazaki Y; Katamine S; Kohno T; Moriuchi R; Miyamoto T; Tomonaga M
    Exp Hematol; 1993 Feb; 21(2):366-71. PubMed ID: 8425574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation of the FGR protein-tyrosine kinase as a consequence of neutrophil activation.
    Gutkind JS; Robbins KC
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8783-7. PubMed ID: 2682659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
    Sharp NA; Luscombe MJ; Clemens MJ
    Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning of the murine c-fgr proto-oncogene cDNA and induction of c-fgr expression by proliferation and activation factors in normal bone marrow-derived monocytic cells.
    Yi TL; Willman CL
    Oncogene; 1989 Sep; 4(9):1081-7. PubMed ID: 2674853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. fgr proto-oncogene mRNA induced in B lymphocytes by Epstein-Barr virus infection.
    Cheah MS; Ley TJ; Tronick SR; Robbins KC
    Nature; 1986 Jan 16-22; 319(6050):238-40. PubMed ID: 3003578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse biologic properties imparted by the c-fgr proto-oncogene.
    Sartor O; Moriuchi R; Sameshima JH; Severino M; Gutkind JS; Robbins KC
    J Biol Chem; 1992 Feb; 267(5):3460-5. PubMed ID: 1737799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression and regulation of the c-src and c-fgr protooncogenes in myelomonocytic cells.
    Willman CL; Stewart CC; Griffith JK; Stewart SJ; Tomasi TB
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4480-4. PubMed ID: 2440024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and expression of c-fgr protooncogene mRNA in Epstein-Barr virus converted cell lines.
    Brickell PM; Patel M
    Br J Cancer; 1988 Dec; 58(6):704-9. PubMed ID: 2852026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific expression and developmental regulation of the human fgr proto-oncogene.
    Ley TJ; Connolly NL; Katamine S; Cheah MS; Senior RM; Robbins KC
    Mol Cell Biol; 1989 Jan; 9(1):92-9. PubMed ID: 2538725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary structure of the human fgr proto-oncogene product p55c-fgr.
    Katamine S; Notario V; Rao CD; Miki T; Cheah MS; Tronick SR; Robbins KC
    Mol Cell Biol; 1988 Jan; 8(1):259-66. PubMed ID: 3275868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the 5' untranslated region of the human c-fgr gene and identification of the major myelomonocytic c-fgr promoter.
    Link DC; Gutkind SJ; Robbins KC; Ley TJ
    Oncogene; 1992 May; 7(5):877-84. PubMed ID: 1373875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fgr expression restricted to subpopulation of monocyte/macrophage lineage in resting conditions is induced in various hematopoietic cells after activation or transformation.
    Hatakeyama S; Iwabuchi K; Ato M; Iwabuchi C; Kajino K; Takami K; Katoh M; Ogasawara K; Good RA; Onoé K
    Microbiol Immunol; 1996; 40(3):223-31. PubMed ID: 8934677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL-2 induction is part of the strategy of Epstein-Barr virus.
    Finke J; Lange W; Mertelsmann R; Dölken G
    Leuk Lymphoma; 1994 Feb; 12(5-6):413-9. PubMed ID: 8180604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.